Tuesday, December 23, 2025
ADVT 
International

Hamas leader Ismael Haniyeh in Cairo for ceasefire talks, hostage release

Darpan News Desk IANS, 20 Dec, 2023 01:12 PM
  • Hamas leader Ismael Haniyeh in Cairo for ceasefire talks, hostage release

Tel Aviv, Dec 20 (IANS) The Hamas leader Ismael Haniyeh on Wednesday reached Cairo, Egypt for negotiations with the Israelis for a possible ceasefire and hostage release.

Haniyeh -- considered to be face of Hamas for International diplomacy will meet top officials of Egyptian government to carry forward the negotiations with Israel for a possible ceasefire and hostage release.

“Haniyeh will meet the Egyptian Intelligence Head Abbas Kamel -- who was part of last negotiations with Mossad Chief David Barnea and Qatari Prime Minister Sheikh Mohammed bin Abdulrahman Al Thani regarding ceasefire and hostage release,” Hamas in a press statement said.

It said that Haniyeh is accompanied by senior Hamas leaders and they will focus on supply of more aid material to Gaza.

“Haniyeh will ask the Israel side to withdrawal the army from Gaza and to rehabilitate the displaced Palestinians within Gaza,” the statement said.

During the temporary one week truce from November 24 to December 1 between Hamas and Israel, the Hamas released 105 hostages while at least 129 hostages are still in Hamas captivity.

The Israelis believe that out of remaining 129 hostages, at least 20 hostages have died.

There are thousands of Palestinians in Israeli jails who have been held without any trials and access to legal counsel.

Israel launched a ground offensive inside Gaza on October 27 after Hamas attacked Israel in a surprise attack on October 7 in which 1200 Israelis were killed and over 200 were taken hostage.

Since the outbreak of hostilities between Hamas and Israel, over 19,667 Palestinians have been killed mostly being children and women.

 

MORE International ARTICLES

African scientists baffled by monkeypox cases in Europe, US

African scientists baffled by monkeypox cases in Europe, US
Cases of the smallpox-related disease have previously been seen only among people with links to central and West Africa. But in the past week, Britain, Spain, Portugal, Italy, U.S., Sweden and Canada all reported infections, mostly in young men who hadn’t previously traveled to Africa. 

African scientists baffled by monkeypox cases in Europe, US

One person killed in shooting in Oakland

One person killed in shooting in Oakland
Police found the victim off the side of a road with apparent gunshot wounds. The man died from his injuries at the scene and his identity is being withheld until his next of kin is notified, the police said.

One person killed in shooting in Oakland

WHO calls on Pfizer to make its COVID pill more available

WHO calls on Pfizer to make its COVID pill more available
WHO Director-General Tedros Adhanom Ghebreyesus said during a news briefing that Pfizer's treatment was still too expensive. He noted that most countries in Latin America had no access to Pfizer’s drug, Paxlovid , which has been shown to cut the risk of COVID-19 hospitalization or death by up to 90%.    

WHO calls on Pfizer to make its COVID pill more available

Rare cases of COVID returning pose questions for Pfizer pill

Rare cases of COVID returning pose questions for Pfizer pill
Paxlovid has become the go-to option against COVID-19 because of its at-home convenience and impressive results in heading off severe disease. The U.S. government has spent more than $10 billion to purchase enough pills to treat 20 million people.    

Rare cases of COVID returning pose questions for Pfizer pill

CDC probing 109 liver illnesses in kids, including 5 deaths

CDC probing 109 liver illnesses in kids, including 5 deaths
About two dozen states reported suspected cases after the Centers for Disease Control and Prevention put out a call for doctors to be on the lookout for surprising cases of hepatitis. The cases date back to late October in children under 10. So far, only nine cases in Alabama have been confirmed.    

CDC probing 109 liver illnesses in kids, including 5 deaths

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

FDA restricts J&J's COVID-19 vaccine due to blood clot risk
FDA officials said in a statement that they decided to restrict J&J's vaccine after taking another look at data on the risk of life-threatening blood clots within two week of vaccination.

FDA restricts J&J's COVID-19 vaccine due to blood clot risk